1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Cardiac Markers Market
2.3. Global Cardiac Markers Market, By Type, 2025 (US$ Million)
2.4. Global Cardiac Markers Market, By Product, 2025 (US$ Million)
2.5. Global Cardiac Markers Market, By Condition, 2025 (US$ Million)
2.6. Global Cardiac Markers Market, By Testing, 2025 (US$ Million)
2.7. Global Cardiac Markers Market, By Geography, 2025 (US$ Million)
2.8. Attractive Investment Proposition by Geography, 2025
3. Cardiac Markers Market: Competitive Analysis
3.1. Market Positioning of Key Cardiac Markers Market Vendors
3.2. Strategies Adopted by Cardiac Markers Market Vendors
4. Cardiac Markers Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Cardiac Markers Market Value, 2024 - 2034, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. Porter's Five Force Model
4.5.1. Supplier Power
4.5.2. Buyer Power
4.5.3. Threat Of Substitutes
4.5.4. Threat Of New Entrants
4.5.5. Competitive Rivalry
4.6. PESTEL Analysis
4.6.1. Political Landscape
4.6.2. Economic Landscape
4.6.3. Social Landscape
4.6.4. Technology Landscape
4.6.5. Environmental Landscape
4.6.6. Legal Landscape
5. Cardiac Markers Market: By Type, 2024-2034, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2025 Versus 2034
5.3. Market Segmentation
5.3.1. Cardiac troponin I and T
5.3.2. CK-MB
5.3.3. Myoglobin
5.3.4. B type natriuretic peptide (BNP) and NT-proBNP
5.3.5. hs-C-Reactive Protein (hs-CRP)
5.3.6. Myeloperoxidase (MPD)
5.3.7. Ischaemia Modified Albumin
5.3.8. Others
6. Cardiac Markers Market: By Product, 2024-2034, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2025 Versus 2034
6.3. Market Segmentation
6.3.1. Instruments
6.3.1.1. Chemiluminescence
6.3.1.2. Immunofluorescence
6.3.1.3. Immunochromatography
6.3.1.4. ELISA
6.3.2. Reagents and Kits
7. Cardiac Markers Market: By Condition, 2024-2034, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2025 Versus 2034
7.3. Market Segmentation
7.3.1. Plaque Formation
7.3.2. Plaque Instability/ Rupture
7.3.3. Myocardial Necrosis and Ischemia
7.3.4. Heart Failure
8. Cardiac Markers Market: By Testing, 2024-2034, USD (Million)
8.1. Market Overview
8.2. Growth & Revenue Analysis: 2025 Versus 2034
8.3. Market Segmentation
8.3.1. Laboratory Testing
8.3.2. Point-of-Care Testing
9. North America Cardiac Markers Market, 2024-2034, USD (Million)
9.1. Market Overview
9.2. Cardiac Markers Market: By Type, 2024-2034, USD (Million)
9.3. Cardiac Markers Market: By Product, 2024-2034, USD (Million)
9.4. Cardiac Markers Market: By Condition, 2024-2034, USD (Million)
9.5. Cardiac Markers Market: By Testing, 2024-2034, USD (Million)
9.6. Cardiac Markers Market: By Region, 2024-2034, USD (Million)
9.6.1.North America
9.6.1.1. U.S.
9.6.1.1.1. Cardiac Markers Market: By Type, 2024-2034, USD (Million)
9.6.1.1.2. Cardiac Markers Market: By Product, 2024-2034, USD (Million)
9.6.1.1.3. Cardiac Markers Market: By Condition, 2024-2034, USD (Million)
9.6.1.1.4. Cardiac Markers Market: By Testing, 2024-2034, USD (Million)
9.6.1.2. Canada
9.6.1.2.1. Cardiac Markers Market: By Type, 2024-2034, USD (Million)
9.6.1.2.2. Cardiac Markers Market: By Product, 2024-2034, USD (Million)
9.6.1.2.3. Cardiac Markers Market: By Condition, 2024-2034, USD (Million)
9.6.1.2.4. Cardiac Markers Market: By Testing, 2024-2034, USD (Million)
9.6.1.3. Rest of North America
9.6.1.3.1. Cardiac Markers Market: By Type, 2024-2034, USD (Million)
9.6.1.3.2. Cardiac Markers Market: By Product, 2024-2034, USD (Million)
9.6.1.3.3. Cardiac Markers Market: By Condition, 2024-2034, USD (Million)
9.6.1.3.4. Cardiac Markers Market: By Testing, 2024-2034, USD (Million)
10. UK and European Union Cardiac Markers Market, 2024-2034, USD (Million)
10.1. Market Overview
10.2. Cardiac Markers Market: By Type, 2024-2034, USD (Million)
10.3. Cardiac Markers Market: By Product, 2024-2034, USD (Million)
10.4. Cardiac Markers Market: By Condition, 2024-2034, USD (Million)
10.5. Cardiac Markers Market: By Testing, 2024-2034, USD (Million)
10.6. Cardiac Markers Market: By Region, 2024-2034, USD (Million)
10.6.1.UK and European Union
10.6.1.1. UK
10.6.1.1.1. Cardiac Markers Market: By Type, 2024-2034, USD (Million)
10.6.1.1.2. Cardiac Markers Market: By Product, 2024-2034, USD (Million)
10.6.1.1.3. Cardiac Markers Market: By Condition, 2024-2034, USD (Million)
10.6.1.1.4. Cardiac Markers Market: By Testing, 2024-2034, USD (Million)
10.6.1.2. Germany
10.6.1.2.1. Cardiac Markers Market: By Type, 2024-2034, USD (Million)
10.6.1.2.2. Cardiac Markers Market: By Product, 2024-2034, USD (Million)
10.6.1.2.3. Cardiac Markers Market: By Condition, 2024-2034, USD (Million)
10.6.1.2.4. Cardiac Markers Market: By Testing, 2024-2034, USD (Million)
10.6.1.3. Spain
10.6.1.3.1. Cardiac Markers Market: By Type, 2024-2034, USD (Million)
10.6.1.3.2. Cardiac Markers Market: By Product, 2024-2034, USD (Million)
10.6.1.3.3. Cardiac Markers Market: By Condition, 2024-2034, USD (Million)
10.6.1.3.4. Cardiac Markers Market: By Testing, 2024-2034, USD (Million)
10.6.1.4. Italy
10.6.1.4.1. Cardiac Markers Market: By Type, 2024-2034, USD (Million)
10.6.1.4.2. Cardiac Markers Market: By Product, 2024-2034, USD (Million)
10.6.1.4.3. Cardiac Markers Market: By Condition, 2024-2034, USD (Million)
10.6.1.4.4. Cardiac Markers Market: By Testing, 2024-2034, USD (Million)
10.6.1.5. France
10.6.1.5.1. Cardiac Markers Market: By Type, 2024-2034, USD (Million)
10.6.1.5.2. Cardiac Markers Market: By Product, 2024-2034, USD (Million)
10.6.1.5.3. Cardiac Markers Market: By Condition, 2024-2034, USD (Million)
10.6.1.5.4. Cardiac Markers Market: By Testing, 2024-2034, USD (Million)
10.6.1.6. Rest of Europe
10.6.1.6.1. Cardiac Markers Market: By Type, 2024-2034, USD (Million)
10.6.1.6.2. Cardiac Markers Market: By Product, 2024-2034, USD (Million)
10.6.1.6.3. Cardiac Markers Market: By Condition, 2024-2034, USD (Million)
10.6.1.6.4. Cardiac Markers Market: By Testing, 2024-2034, USD (Million)
11. Asia Pacific Cardiac Markers Market, 2024-2034, USD (Million)
11.1. Market Overview
11.2. Cardiac Markers Market: By Type, 2024-2034, USD (Million)
11.3. Cardiac Markers Market: By Product, 2024-2034, USD (Million)
11.4. Cardiac Markers Market: By Condition, 2024-2034, USD (Million)
11.5. Cardiac Markers Market: By Testing, 2024-2034, USD (Million)
11.6. Cardiac Markers Market: By Region, 2024-2034, USD (Million)
11.6.1.Asia Pacific
11.6.1.1. China
11.6.1.1.1. Cardiac Markers Market: By Type, 2024-2034, USD (Million)
11.6.1.1.2. Cardiac Markers Market: By Product, 2024-2034, USD (Million)
11.6.1.1.3. Cardiac Markers Market: By Condition, 2024-2034, USD (Million)
11.6.1.1.4. Cardiac Markers Market: By Testing, 2024-2034, USD (Million)
11.6.1.2. Japan
11.6.1.2.1. Cardiac Markers Market: By Type, 2024-2034, USD (Million)
11.6.1.2.2. Cardiac Markers Market: By Product, 2024-2034, USD (Million)
11.6.1.2.3. Cardiac Markers Market: By Condition, 2024-2034, USD (Million)
11.6.1.2.4. Cardiac Markers Market: By Testing, 2024-2034, USD (Million)
11.6.1.3. India
11.6.1.3.1. Cardiac Markers Market: By Type, 2024-2034, USD (Million)
11.6.1.3.2. Cardiac Markers Market: By Product, 2024-2034, USD (Million)
11.6.1.3.3. Cardiac Markers Market: By Condition, 2024-2034, USD (Million)
11.6.1.3.4. Cardiac Markers Market: By Testing, 2024-2034, USD (Million)
11.6.1.4. Australia
11.6.1.4.1. Cardiac Markers Market: By Type, 2024-2034, USD (Million)
11.6.1.4.2. Cardiac Markers Market: By Product, 2024-2034, USD (Million)
11.6.1.4.3. Cardiac Markers Market: By Condition, 2024-2034, USD (Million)
11.6.1.4.4. Cardiac Markers Market: By Testing, 2024-2034, USD (Million)
11.6.1.5. South Korea
11.6.1.5.1. Cardiac Markers Market: By Type, 2024-2034, USD (Million)
11.6.1.5.2. Cardiac Markers Market: By Product, 2024-2034, USD (Million)
11.6.1.5.3. Cardiac Markers Market: By Condition, 2024-2034, USD (Million)
11.6.1.5.4. Cardiac Markers Market: By Testing, 2024-2034, USD (Million)
11.6.1.6. Rest of Asia Pacific
11.6.1.6.1. Cardiac Markers Market: By Type, 2024-2034, USD (Million)
11.6.1.6.2. Cardiac Markers Market: By Product, 2024-2034, USD (Million)
11.6.1.6.3. Cardiac Markers Market: By Condition, 2024-2034, USD (Million)
11.6.1.6.4. Cardiac Markers Market: By Testing, 2024-2034, USD (Million)
12. Latin America Cardiac Markers Market, 2024-2034, USD (Million)
12.1. Market Overview
12.2. Cardiac Markers Market: By Type, 2024-2034, USD (Million)
12.3. Cardiac Markers Market: By Product, 2024-2034, USD (Million)
12.4. Cardiac Markers Market: By Condition, 2024-2034, USD (Million)
12.5. Cardiac Markers Market: By Testing, 2024-2034, USD (Million)
12.6. Cardiac Markers Market: By Region, 2024-2034, USD (Million)
12.6.1.Latin America
12.6.1.1. Brazil
12.6.1.1.1. Cardiac Markers Market: By Type, 2024-2034, USD (Million)
12.6.1.1.2. Cardiac Markers Market: By Product, 2024-2034, USD (Million)
12.6.1.1.3. Cardiac Markers Market: By Condition, 2024-2034, USD (Million)
12.6.1.1.4. Cardiac Markers Market: By Testing, 2024-2034, USD (Million)
12.6.1.2. Mexico
12.6.1.2.1. Cardiac Markers Market: By Type, 2024-2034, USD (Million)
12.6.1.2.2. Cardiac Markers Market: By Product, 2024-2034, USD (Million)
12.6.1.2.3. Cardiac Markers Market: By Condition, 2024-2034, USD (Million)
12.6.1.2.4. Cardiac Markers Market: By Testing, 2024-2034, USD (Million)
12.6.1.3. Rest of Latin America
12.6.1.3.1. Cardiac Markers Market: By Type, 2024-2034, USD (Million)
12.6.1.3.2. Cardiac Markers Market: By Product, 2024-2034, USD (Million)
12.6.1.3.3. Cardiac Markers Market: By Condition, 2024-2034, USD (Million)
12.6.1.3.4. Cardiac Markers Market: By Testing, 2024-2034, USD (Million)
13. Middle East and Africa Cardiac Markers Market, 2024-2034, USD (Million)
13.1. Market Overview
13.2. Cardiac Markers Market: By Type, 2024-2034, USD (Million)
13.3. Cardiac Markers Market: By Product, 2024-2034, USD (Million)
13.4. Cardiac Markers Market: By Condition, 2024-2034, USD (Million)
13.5. Cardiac Markers Market: By Testing, 2024-2034, USD (Million)
13.6. Cardiac Markers Market: By Region, 2024-2034, USD (Million)
13.6.1.Middle East and Africa
13.6.1.1. GCC
13.6.1.1.1. Cardiac Markers Market: By Type, 2024-2034, USD (Million)
13.6.1.1.2. Cardiac Markers Market: By Product, 2024-2034, USD (Million)
13.6.1.1.3. Cardiac Markers Market: By Condition, 2024-2034, USD (Million)
13.6.1.1.4. Cardiac Markers Market: By Testing, 2024-2034, USD (Million)
13.6.1.2. Africa
13.6.1.2.1. Cardiac Markers Market: By Type, 2024-2034, USD (Million)
13.6.1.2.2. Cardiac Markers Market: By Product, 2024-2034, USD (Million)
13.6.1.2.3. Cardiac Markers Market: By Condition, 2024-2034, USD (Million)
13.6.1.2.4. Cardiac Markers Market: By Testing, 2024-2034, USD (Million)
13.6.1.3. Rest of Middle East and Africa
13.6.1.3.1. Cardiac Markers Market: By Type, 2024-2034, USD (Million)
13.6.1.3.2. Cardiac Markers Market: By Product, 2024-2034, USD (Million)
13.6.1.3.3. Cardiac Markers Market: By Condition, 2024-2034, USD (Million)
13.6.1.3.4. Cardiac Markers Market: By Testing, 2024-2034, USD (Million)
14. Company Profile
14.1. Abbott Laboratories, Inc. (Company Overview, Financial Performance, Product Portfolio, Strategic Initiatives)
14.2. Roche Diagnostics Limited
14.3. Danaher Corporation
14.4. Bio-Rad Laboratories, Inc.
14.5. Becton, Dickinson and Company
14.6. LSI Medience Corporation
14.7. Beckman Coulter, Inc. (Danaher Corporation)
14.8. bioMerieux SA
14.9. Ortho Clinical Diagnostics
14.10. Siemens Healthcare Diagnostics
14.11. Randox Laboratories Ltd.
14.12. Tosoh Bioscience
14.13. Quest Diagnostics, Inc.
